Mirror Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MIRROR PHARMS, and what generic and branded alternatives to MIRROR PHARMS drugs are available?
MIRROR PHARMS has two approved drugs.
Drugs and US Patents for Mirror Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mirror Pharms | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN | acetaminophen; propoxyphene napsylate | TABLET;ORAL | 077821-001 | Feb 11, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Mirror Pharms Llc | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | TABLET;ORAL | 040883-001 | Dec 23, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.